the U.S. childhood immunization schedule, the grid of colored bars pediatricians share with parents, recommends a set of vaccines given from birth through adolescence to prevent a range of serious infections. The basic structure has been in place since 1995, when federal health officials and medical organizations first issued a unified national standard, though new vaccines have been added regularly as science advanced.
Vaccines on the childhood schedule have been tested in controlled trials involving millions of participants,and they are continuously monitored for safety after being rolled out.The schedule represents the accumulated knowledge of decades of research. It has made the diseases it targets so rare that many parents have never seen them.
Centers for Disease Control and Prevention
But the schedule is now under scrutiny.
On Dec. 16, 2025, the Centers for Disease Control and Prevention adopted its first major change to the childhood immunization schedule, under Kennedy’s leadership. The agency accepted an advisory committee’s vote to drop a long-held proposal that all newborns be vaccinated against hepatitis B, despite no new evidence that questions the vaccine’s long-standing safety record.
Health and Human Services Secretary Robert F. Kennedy Jr., who has cast doubt on vaccine safety for decades, has said he plans to further scrutinize the vaccines children receive.I’m an infectious disease physician who treats vaccine-preventable diseases and reviews the clinical trial evidence behind immunization recommendations.the vacci## New viral vaccines
Through the 1960s, vaccines against measles (1963), mumps (1967) and rubella (1969) were licensed and eventually combined into what’s known as the MMR shot in 1971.Each addition followed a similar pattern: a disease that killed or disabled thousands of children annually, a vaccine that proved safe and effective in trials, and a recommendation that transformed a seemingly inevitable childhood illness into something preventable.
The rubella vaccine went beyond protecting the children who received it. Rubella, also called German measles, is mild in children but devastating to fetuses, causing deafness, heart defects and intellectual disabilities when pregnant women are infected.
A Rubella epidemic in 1964 and 1965 drove this point home: 12.5 million infections and 20,000 cases of congenital rubella syndrome left thousands of children deaf or blind. Vaccinating children also helped protect pregnant women by curbing the spread of infection. By 2015, rubella had been eliminated from the Americas.
Technology opens new doors
Table of Contents
One limitation of some early bacterial vaccines was that they didn’t work well in infants. Young children’s immune systems couldn’t mount a strong response to the sugar coating on certain bacteria. In the 1980s, scientists developed a method called conjugate vaccine technology, in which sugars on bacterial pathogens are linked to proteins that the immune system – even in infants – can more easily respond to.
The first target of this innovation was a bacterium called Haemophilus influenzae Type b, or Hib. Before vaccination, Hib was the leading cause of bacterial meningitis in American children, causing roughly 20,000 cases of the disease annually and killing hundreds.
The Hib conjugate vaccine was licensed for use in infants in 1990,and within five years Hib disease in young children dropped by more than 99%. Most pediatricians practicing today have never seen a case.
Hepatitis B and the safety net
In 1991, the CDC added hepatitis B vaccination at birth to the schedu# A rollback of the RSV vaccine recommendation for pregnant people is a worrying sign of things to come
The US Centers for Disease Control and Prevention recently reversed its recommendation that pregnant people be vaccinated against respiratory syncytial virus (RSV).This decision, made by the newly appointed Health Secretary, is a departure from decades of established practice and raises concerns about the future of evidence-based vaccine policy.
In 2021, the Advisory Committee on Immunization Practices (ACIP), the independent panel that advises the CDC on vaccines, recommended RSV vaccination for pregnant people to protect their babies from severe illness. This recommendation was based on rigorous scientific evidence demonstrating the vaccine’s safety and effectiveness. The vaccine works by prompting the mother’s immune system to produce antibodies that pass to the baby, providing protection in the first few months of life.
The CDC withdrew the recommendation in December 2024, citing a lack of data on long-term effects. However, this justification is unusual. Vaccine recommendations are not always contingent on decades of long-term data; they are made based on the best available evidence at the time, weighing risks and benefits.
This isn’t the first time a vaccine recommendation has been altered. Over the years, the ACIP has added vaccines for diseases like rotavirus (with an earlier version withdrawn after safety monitoring detected a rare side effect); and HPV, also in 2006.
Each addition followed the same rigorous process: evidence review, risk-benefit analysis and a public vote by the advisory committee.
More vaccines, less burden
One fact often surprises parents: Despite the increase in recommended vaccines, the number of immune-stimulating molecules in those vaccines, called antigens, has dropped dramatically since the 1980s, which means they are less demanding on a child’s immune system.
the whole-cell pertussis vaccine used in the 1980s alone contained roughly 3,000 antigens. Today’s entire schedule contains fewer than 160 antigens,thanks to advances in vaccine technology that allow precise targeting of only the components needed for protection.
What lies ahead
For decades, ACIP recommended changes to the childhood schedule only when new evidence or clear shifts in disease risk demanded it. Rolling back a long-standing recommendation with no new safety data represents a significant break from that norm.
In june 2025, Kennedy fired all 17 members of ACIP and replaced them with his own choices, many of whom had a history of anti-vaccine views.
Given this and other unprecedented changes Kennedy has made to vaccine policy in his first year as health secretary, this is unlikely to be the last such reversal.
